Evaluation of Adverse Drug Reactions in patients receiving Antiretroviral Therapy
Not Applicable
- Conditions
- Health Condition 1: B20- Human immunodeficiency virus [HIV]disease
- Registration Number
- CTRI/2024/05/067521
- Lead Sponsor
- Government Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1) Patients of any gender on Anti Retroviral Therapy
(ART) attending ART Centre.
2) Patients of age above 18 years.
Exclusion Criteria
1) Patients who disagree to give consent.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of Adverse Drug Reactions in Patients on Anti-Retroviral TherapyTimepoint: At baseline <br/ ><br>
- Secondary Outcome Measures
Name Time Method i.To estimate the Severity & <br/ ><br>Preventability of ADRs in <br/ ><br>patients on ART. <br/ ><br>ii. To determine risk factors associated with the ADRs in patients on ART. <br/ ><br>iii. To evaluate ADRs in patients with co-infection receiving ART. <br/ ><br>iv. To assess whether demographic factors are responsible for the ADRs.Timepoint: At baseline <br/ ><br>